@ TraderP - thanks heaps for sharing this
Good to see that the top 20 holders in CDX have generally been buying rather than selling - obviously except for Paul Cozzi earlier this year.
I am presuming that Paul Cozzi & Paul Joseph Cozzi are the same person - as Joseph appears to be Paul's middle name?
So if this is the case, Paul was still a substantial holder at a bit over 7% of CDX (total of approximately 8.8m shares) before the latest CR.
Personally, I am really looking forward to some good news here - especially regarding the FDA approval for the Pulse!!
Have held for a few years now, and am still as confident as ever in CDX - especially once we start receiving significant recurring revenue streams from the Pulse product.
But I must admit these "macro effected" markets are getting very tough to stomach - with all my (mostly tech / fintech / medtech) microcaps getting smashed pretty much every day
Add to My Watchlist
What is My Watchlist?
